Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

MLA

Díez-Alonso, Laura, et al. “Engineered T Cells Secreting Anti-BCMA T Cell Engagers Control Multiple Myeloma and Promote Immune Memory in Vivo.” Science Translational Medicine, vol. 16, no. 734, Feb. 2024, p. eadg7962. EBSCOhost, https://doi.org/10.1126/scitranslmed.adg7962.

APA

Díez-Alonso, L., Falgas, A., Arroyo-Ródenas, J., Romencín, P. A., Martínez, A., Gómez-Rosel, M., Blanco, B., Jiménez-Reinoso, A., Mayado, A., Pérez-Pons, A., Aguilar-Sopeña, Ó., Ramírez-Fernández, Á., Segura-Tudela, A., Perez-Amill, L., Tapia-Galisteo, A., Domínguez-Alonso, C., Rubio-Pérez, L., Jara, M., Solé, F., … Álvarez-Vallina, L. (2024). Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo. Science Translational Medicine, 16(734), eadg7962. https://doi.org/10.1126/scitranslmed.adg7962

Chicago

Díez-Alonso, Laura, Aïda Falgas, Javier Arroyo-Ródenas, Paola A Romencín, Alba Martínez, Marina Gómez-Rosel, Belén Blanco, et al. 2024. “Engineered T Cells Secreting Anti-BCMA T Cell Engagers Control Multiple Myeloma and Promote Immune Memory in Vivo.” Science Translational Medicine 16 (734): eadg7962. doi:10.1126/scitranslmed.adg7962.